Residence, Clinical Features, and Genetic Risk Factors Associated with Symptoms of COVID-19 in a Cohort of Older People in Madrid

Background: The older population has been especially affected by the severe acute respiratory syndrome coronavirus 2 pandemic (COVID-19). Objective: The aim of the study was to explore the incidence, severity, mortality rate, clinical features, and risk factors of symptoms of COVID-19 in home-dwelling older people, and its association with type of residence, cognitive deterioration, and neurodegenerative diseases. Methods: Data about symptoms of COVID-19 were collected through a telephone survey in the cohort of 913 older volunteers of the Vallecas Project, aged 75–90 years, most of them (902) home-dwelling, in Madrid, Spain. The association of demographic and anthropometric measures, genetic polymorphisms, comorbidities, life habits, type of residence, and frailty surrogates were explored as potential risk factors for the incidence, severity, and mortality of COVID-19 in the older population. Findings: Sixty-two cases reported symptoms compatible with COVID-19; 6 of them had died, 4 in their home and 2 in the nursing home. Moderate/severe cases were significantly older and more frequently males. The APOE ε4 allele was associated with the presence of symptoms of COVID-19. Higher systolic blood pressure, more intense smoking habit, more alcohol intake, lower consumption of coffee and tea, and cognitive impairment were associated with disease severity. Conclusions: The estimated incidence of symptomatic COVID-19 in this older cohort of Madrid was 6.8%, with an overall mortality rate of 0.7% (18.2% in those living in a nursing home) and a fatality rate of 9.9%. Our exploratory study indicates that life habits, other clinical conditions and, the ε4 variant of the APOE gene are associated with the presence and clinical severity of coronavirus infection.

[1]  M. Hernán,et al.  Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study , 2020, The Lancet.

[2]  D. Melzer,et al.  APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort , 2020, medRxiv.

[3]  M. Wolfert,et al.  SARS-CoV-2 spike protein binds heparan sulfate in a length- and sequence-dependent manner , 2020, bioRxiv.

[4]  D. W. Maybury,et al.  A note on COVID-19 seroprevalence studies: a meta-analysis using hierarchical modelling , 2020, medRxiv.

[5]  Amanda Wong,et al.  The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis , 2020, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[6]  Char Leung,et al.  Risk factors for predicting mortality in elderly patients with COVID-19: A review of clinical data in China , 2020, Mechanisms of Ageing and Development.

[7]  J. Ioannidis,et al.  COVID-19 antibody seroprevalence in Santa Clara County, California , 2020, medRxiv.

[8]  A. Lovato,et al.  Clinical Presentation of COVID-19: A Systematic Review Focusing on Upper Airway Symptoms , 2020, Ear, nose, & throat journal.

[9]  Atar Baer,et al.  COVID-19 in a Long-Term Care Facility — King County, Washington, February 27–March 9, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[10]  C. Vardavas,et al.  COVID-19 and smoking: A systematic review of the evidence , 2020, Tobacco induced diseases.

[11]  Hong Jiang,et al.  Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up , 2020, Journal of Infection.

[12]  Bo Li,et al.  Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China , 2020, Clinical Research in Cardiology.

[13]  Kai Liu,et al.  Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients , 2020, Journal of Infection.

[14]  Michael Roth,et al.  Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? , 2020, The Lancet Respiratory Medicine.

[15]  T. Tsang COVID-19, Australia: Epidemiology Report 6 (Reporting week ending 19:00 AEDT 7 March 2020). , 2020, Communicable diseases intelligence.

[16]  Report on the Epidemiological Features of Coronavirus Disease 2019 (COVID-19) Outbreak in the Republic of Korea from January 19 to March 2, 2020 , 2020, Journal of Korean medical science.

[17]  H. Rothan,et al.  The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak , 2020, Journal of Autoimmunity.

[18]  A. Yashin,et al.  The APOE ε4 allele is associated with a reduction in FEV1/FVC in women: A cross-sectional analysis of the Long Life Family Study , 2018, PloS one.

[19]  R. Cunha,et al.  Chronic coffee consumption and respiratory disease: A systematic review , 2018, The clinical respiratory journal.

[20]  S. Tavazoie,et al.  LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer , 2018, Cell.

[21]  S. Levine,et al.  Emerging Roles of Apolipoprotein E and Apolipoprotein A-I in the Pathogenesis and Treatment of Lung Disease. , 2016, American journal of respiratory cell and molecular biology.

[22]  J. Burgos,et al.  Effect of Apolipoprotein E on the Cerebral Load of Latent Herpes Simplex Virus Type 1 DNA , 2006, Journal of Virology.

[23]  J. Haines,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.

[24]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[25]  Diane Podsiadlo,et al.  The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons , 1991, Journal of the American Geriatrics Society.

[26]  M. Emi,et al.  Genotyping and sequence analysis of apolipoprotein E isoforms. , 1988, Genomics.

[27]  T. Kurosaki,et al.  Measurement of functional activities in older adults in the community. , 1982, Journal of gerontology.

[28]  M. Wozniak,et al.  Herpes simplex virus type 1, apolipoprotein E, and cholesterol: a dangerous liaison in Alzheimer's disease and other disorders. , 2006, Progress in lipid research.

[29]  P. Donaldson,et al.  Apolipoprotein epsilon3 allele is associated with persistent hepatitis C virus infection. , 2006, Gut.

[30]  R. Mahley,et al.  Apolipoprotein E: far more than a lipid transport protein. , 2000, Annual review of genomics and human genetics.

[31]  C. Mamotte,et al.  Apolipoprotein epsilon 4 homozygosity in young men with coronary heart disease. , 1992, Lancet.